Acima Private Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Acima Private Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$897K	Hold	1,806	–	–	0.26%	53
2026 Q1	$806K	Hold	1,806	–	–	0.25%	57
2025 Q4	$819K	Hold	1,806	–	–	0.25%	57
2025 Q3	$707K	Hold	1,806	–	–	0.22%	61
2025 Q2	$804K	Hold	1,806	–	–	0.27%	57
2025 Q1	$876K	Hold	1,806	–	–	0.31%	50
2024 Q4	$727K	Sell	1,806 -1,275	-41%	-$591K	0.24%	63
2024 Q3	$1.43M	Hold	3,081	–	–	0.48%	43
2024 Q2	$1.44M	Hold	3,081	–	–	0.53%	40
2024 Q1	$1.29M	Hold	3,081	–	–	0.47%	47
2023 Q4	$1.25M	Hold	3,081	–	–	0.49%	46
2023 Q3	$1.07M	Sell	3,081 -299	-9%	-$105K	0.48%	52
2023 Q2	$1.19M	Sell	3,380 -58	-2%	-$19.5K	0.57%	46
2023 Q1	$1.08M	Hold	3,438	–	–	0.53%	49
2022 Q4	$993K	Sell	3,438 -401	-10%	-$122K	0.51%	53
2022 Q3	$1.11M	Hold	3,839	–	–	0.57%	46
2022 Q2	$1.08M	Hold	3,839	–	–	0.54%	49
2022 Q1	$1M	Hold	3,839	–	–	0.46%	54
2021 Q4	$843K	Hold	3,839	–	–	0.36%	66
2021 Q3	$696K	Hold	3,839	–	–	0.32%	73
2021 Q2	$774K	Hold	3,839	–	–	0.36%	68
2021 Q1	$825K	Hold	3,839	–	–	0.41%	62
2020 Q4	$907K	Hold	3,839	–	–	0.47%	59
2020 Q3	$1.04M	Sell	3,839 -16	-0.4%	-$4.41K	0.63%	45
2020 Q2	$1.12M	Hold	3,855	–	–	0.72%	40
2020 Q1	$917K	Hold	3,855	–	–	0.71%	36
2019 Q4	$844K	Hold	3,855	–	–	0.58%	43
2019 Q3	$653K	Hold	3,855	–	–	0.5%	48
2019 Q2	$707K	Hold	3,855	–	–	0.56%	43
2019 Q1	$709K	Buy	3,855 +16	+0.4%	+$2.96K	0.61%	39
2018 Q4	$636K	Buy	+3,839	New	+$665K	0.62%	39

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Acima Private Wealth's VRTX Position: Q2 2026 in Review

Acima Private Wealth held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 1,806 shares worth $897K. The position accounts for 0.26% of the portfolio, ranked #53.

Acima Private Wealth first reported a position in VRTX in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.44M in Q2 2024. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Acima Private Wealth held 1,806 shares of Vertex Pharmaceuticals worth $897K as of Q2 2026.
Acima Private Wealth left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up 0.26% of Acima Private Wealth's portfolio in Q2 2026, its #53 holding.
Acima Private Wealth first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 31 quarters since.
Acima Private Wealth's Vertex Pharmaceuticals position peaked at $1.44M in Q2 2024.
1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Acima Private Wealth's 13F filing for Q2 2026, filed 6 Jul 2026.